Extracellular vesicles as a tool to predict drug clearance and improve precision pharmacotherapy

Project Information

EVPERS

Grant agreement ID: 101028473

DOI

10.3030/101028473

Project closed

EC signature date 14 April 2021

Start date 1 January 2022

End date 31 December 2023

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 162 806,40

EU contribution

€ 162 806,40

Coordinated by

UNIVERSITATSKLINIKUM HEIDELBERG
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (3)

Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers?

Author(s): María Bucci-Muñoz; Aldana Magalí Gola; Juan Pablo Rigalli; María Paula Ceballos; María Laura Ruiz
Published in: Life (Basel), 2023, ISSN 2075-1729
Publisher: MDPI
DOI: 10.3390/life13081633

Involvement of ceramide biosynthesis in increased extracellular vesicle release in Pkd1 knock out cells

Author(s): Valentina Carotti; Jenny van der Wijst; Eric H. J. Verschuren; Luco Rutten; Nico Sommerdijk; Charlotte Kaffa; Vera Sommers; Juan P. Rigalli; Joost G. J. Hoenderop
Published in: Frontiers in Endocrinology, 2022, ISSN 1664-2392
Publisher: Frontiers Media
DOI: 10.3389/fendo.2022.1005639

Extracellular Vesicles as Surrogates for Drug Metabolism and Clearance: Promise vs. Reality

Author(s): Anna Gagliardi; Gzona Bajraktari-Sylejmani; Elisabetta Barocelli; Johanna Weiss; Juan Pablo Rigalli
Published in: Life (Basel), 2023, ISSN 2075-1729
Publisher: MDPI
DOI: 10.3390/life13081745